Latest News Releases From The Newsroom
PDUFA Extension Fuels Iovance Biotherapeutics; PTC Therapeutics Faces Setback
September 15th, 2023
Shares of Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) surged over 10% after the U.S. Food and Drug Administration (FDA) extended the Prescription Drug User Fee Act (PDUFA) for lifileucel due to resource constraints. The new target action date is . Read more
Earnings Reaction Wave: Adobe Dips, eGain Climbs
September 14th, 2023
Adobe Inc. (Nasdaq: ADBE), a prominent software company, reported robust third-quarter fiscal 2023 earnings, with an EPS of $4.09, surpassing the consensus EPS estimate of $3.98. The company's quarterly sales reached $4.89 billion, slightly above ana. Read more
Breaking News: AMC's $325.5M Equity Raise and Draganfly's Defense Orders
September 14th, 2023
AMC Entertainment Holdings, Inc. (NYSE: AMC) said that it successfully raised approximately $325.5 million in new equity capital by selling 40 million shares at an average price of around $8.14 per share, before commissions and fees. $AMC was trad. Read more
Redburn Partners: Carnival and Norwegian Cruise Line are a Buy
September 14th, 2023
Carnival Corporation & plc (NYSE: CCL), a leading cruise line company, has been upgraded by Redburn Partners from Neutral to Buy, along with a price target of $23. With $CCL closing at $15.02 on Wednesday, this price target suggests a potential up. Read more
Semtech Posts Upbeat Results, Outlook Falls Short; FDA Panel Backs Alnylam's Patisiran
September 13th, 2023
Semtech Corporation (Nasdaq: SMTC), a technology company specializing in semiconductor solutions, reported earnings of $0.11 per share for the second quarter of fiscal 2024, surpassing the consensus EPS estimate of $0.02. Quarterly sales for Semtech . Read more
IBEX Misses Estimates, Guides Revenue Below-Consensus
September 13th, 2023
IBEX Limited (Nasdaq: IBEX), a company specializing in customer support solutions, reported earnings of $0.33 per share for the fourth quarter of fiscal 2023. This figure fell short of the consensus EPS estimate of $0.49. Quarterly sales for IBEX amo. Read more
REV Group Beats Estimates; Bullish View On Immunocore
September 13th, 2023
REV Group, Inc. (NYSE: REVG) exceeded expectations in its third-quarter fiscal 2023 earnings report, posting adjusted earnings of $0.35 per share compared to the consensus EPS estimate of $0.23. The company also outperformed in terms of quarterly sal. Read more
Spirit Airlines Lowers Outlook; Alnylam Stock Halted Amid FDA Panel Review
September 13th, 2023
Shares of Spirit Airlines, Inc. (NYSE: SAVE) experienced a dip in pre-market trading as it revised downwardly its third-quarter 2023 outlook. The company now anticipates revenues between $1.245 billion and $1.255 billion, a notable decrease from its . Read more
Momentum Builds: Workhorse's IRS Determination; Edgio's Upbeat Q2 Results
September 13th, 2023
Shares of Workhorse Group Inc. (Nasdaq: WKHS) soared over 20% in after-hours trading following the company's announcement of IRS approval as a qualified manufacturer for the Commercial Clean Vehicle Credit. This approval opens the door for Workhorse . Read more
InnovAge Posts Mixed Results; Lockheed Martin Bags $841.4M+ Contract Modification
September 12th, 2023
InnovAge Holding Corp. (Nasdaq: INNV), a healthcare company, posted a fourth-quarter fiscal 2023 loss of $(0.09) per share, falling short of the consensus estimate loss of $(0.03). Nevertheless, the company reported quarterly sales of $176.87 million. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
NJCP Football League Provides Development and Opportunity for Athletes Pursuing the Next Level
March 20th, 2026March 19th, 2026How High School Graduates Can Kickstart Their Football Career
March 18th, 2026




Member Login